Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net (decrease) increase in net assets from operations $ (9,125,901) $ 11,773,670
Adjustments to reconcile net (decrease) increase in net assets to net cash provided by operating activities:    
Investments in portfolio companies (3,309,755) (11,070,497)
Proceeds from sale of portfolio investments 955,357 19,404,876
Proceeds from loan repayments 16,831,276 5,446,760
Net realized loss (gain) on sales and dispositions of portfolio investments 2,001,997 (11,108,282)
Change in unrealized appreciation/depreciation on investments 11,902,301 776,811
Deferred income tax benefit (114,728) (328,586)
Amortization 18,750 18,750
Original issue discount amortization (37,804) (21,006)
Non-cash conversion of debenture interest (1,841,203) (1,338,517)
Non-cash conversion of loan modification fee (15,000)  
Change in interest receivable allowance 25,337  
Changes in operating assets and liabilities:    
Decrease (increase) in interest receivable 148,456 (163,647)
Increase in other assets (17,073) (277,653)
Increase in prepaid income taxes (14,324) (57,733)
Decrease in accounts payable and accrued expenses (27,592) (41,135)
Decrease in due to investment adviser (1,655,621) (491,814)
(Decrease) increase in capital gains incentive fees payable (1,565,000) 2,066,300
Decrease in deferred revenue (150,368) (38,637)
Total adjustments 23,135,006 2,775,990
Net cash provided by operating activities 14,009,105 14,549,660
Cash flows from financing activities:    
Net repayment of line of credit (600,000) (12,350,000)
Payment of cash dividend (4,753,163) (2,142,247)
Net cash used in financing activities (5,353,163) (14,492,247)
Net increase in cash 8,655,942 57,413
Cash:    
Beginning of period 834,805 3,295,321
End of period $ 9,490,747 $ 3,352,734